Patents by Inventor Jay Lawrence TUTTLE

Jay Lawrence TUTTLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250034243
    Abstract: The present invention generally relates to the treatment of ulcerative colitis with an anti-IL-23p19 antibody, in particular dosage regimens for the treatment of the disease.
    Type: Application
    Filed: October 16, 2024
    Publication date: January 30, 2025
    Inventors: James Benedict CANAVAN, Stuart William FRIEDRICH, Kathryn Ann KRUEGER, Catherine MILCH, Jay Lawrence TUTTLE
  • Patent number: 12152072
    Abstract: The present invention generally relates to the treatment of ulcerative colitis with an anti-IL-23p19 antibody, in particular dosage regimens for the treatment of the disease.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: November 26, 2024
    Inventors: James Benedict Canavan, Stuart William Friedrich, Kathryn Ann Krueger, Catherine Milch, Jay Lawrence Tuttle
  • Publication number: 20220064280
    Abstract: The present invention generally relates to the treatment of psoriasis with an antibody that binds to the p19 subunit of human IL-23, in particular dosage regimens for the treatment of the disease.
    Type: Application
    Filed: September 5, 2019
    Publication date: March 3, 2022
    Inventors: STUART WILLIAM FRIEDRICH, Paul Alan Klekotka, Jay Lawrence Tuttle
  • Publication number: 20220040299
    Abstract: The present invention generally relates to the treatment of Crohn's Disease with an anti-IL-23p19 antibody, particularly dosage regimens for the treatment of the disease.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 10, 2022
    Inventors: STUART WILLIAM FRIEDRICH, PAUL FREDERICK POLLACK, JAY LAWRENCE TUTTLE
  • Publication number: 20210032325
    Abstract: The present invention generally relates to the treatment of ulcerative colitis with an anti-IL-23p19 antibody, in particular dosage regimens for the treatment of the disease.
    Type: Application
    Filed: March 28, 2019
    Publication date: February 4, 2021
    Inventors: James Benedict CANAVAN, Stuart William FRIEDRICH, Kathryn Ann KRUEGER, Catherine MILCH, Jay Lawrence TUTTLE